SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-008149
Filing Date
2023-03-15
Accepted
2023-03-15 16:19:38
Documents
5
Effectiveness Date
2023-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 dice_s-8_march_2023.htm S-8 249826
2 EX-5.1 dice-ex5_1.htm EX-5 19040
3 EX-23.1 dice-ex23_1.htm EX-23 3400
4 EX-FILING FEES dice-exfiling_fees.htm EX-FILING FEES 39860
5 GRAPHIC img5456481_0.jpg GRAPHIC 22395
  Complete submission text file 0000950170-23-008149.txt   344351
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270563 | Film No.: 23735459
SIC: 2834 Pharmaceutical Preparations